Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
Phenylacetic acid is an agent used as an adjunct to treat acute hyperammonemia and associated encephalopathy in adult and pediatric patients with deficiencies in enzymes of the urea cycle. Phenylacetic acid is an organic compound containing a phenyl functional group and a carboxylic acid functional group.
- Primary indication
- For use as adjunctive therapy for the treatment of acute hyperammonemia and associated encephalopathy in patients with deficiencies in enzymes of the urea cycle.Curator reviewed · 1 structured indication
- Formula / weight
- C8H8O2 · 136.1479 g/mol (avg)
- First approval
- United States, 2005
- Also known as
- .ALPHA.-TOLUIC ACID · .OMEGA.-PHENYLACETIC ACID · 2-PHENYLACETIC ACID · ACETIC ACID, PHENYL- · ANTINEOPLASTON AS 2-1 COMPONENT PHENYLACETIC ACID
- Code names
- FEMA NO. 2878 · NSC-125718
- Brand names
- Ammonul
Resolves to
Clinical / RWD
Structure
InChIKey
WLJVXDMOQOGPHL-UHFFFAOYSA-NSMILESOC(=O)CC1=CC=CC=C1Targets
What you can answer from here — as of September 23, 2026
1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
Which drugs share a target with Phenylacetic acid, and which of those have an active Phase 3 trial?